160 related articles for article (PubMed ID: 38765679)
1. PAM-1: an antimicrobial peptide with promise against ceftazidime-avibactam resistant
Han Y; Zhang Y; Zhang X; Huang Z; Kong J; Wang X; Chen L; Wang Y; Cao J; Zhou T; Shen M
Front Microbiol; 2024; 15():1291876. PubMed ID: 38765679
[TBL] [Abstract][Full Text] [Related]
2. Octominin: An antimicrobial peptide with antibacterial and anti-inflammatory activity against carbapenem-resistant Escherichia coli both in vitro and in vivo.
Kong J; Wang Y; Han Y; Zhou H; Huang Z; Zhang X; Zhou C; Cao J; Zhou T
J Glob Antimicrob Resist; 2023 Dec; 35():172-180. PubMed ID: 37716532
[TBL] [Abstract][Full Text] [Related]
3. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Activity of Imipenem in Combination with Ceftazidime/Avibactam or Avibactam against Non-MBL-Producing Extensively Drug-Resistant Pseudomonas aeruginosa.
Zhang Y; Zhao J; Han J; Fan Y; Xiong Z; Zou X; Li B; Liu X; Li Z; Lu B; Cao B
Microbiol Spectr; 2022 Apr; 10(2):e0274021. PubMed ID: 35315696
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases-co-producing carbapenem-resistant Enterobacter cloacae complex.
Li W; Zhang J; Fu Y; Wang J; Liu L; Long W; Yu K; Li X; Wei C; Liang X; Wang J; Li C; Zhang X
Eur J Clin Microbiol Infect Dis; 2024 May; ():. PubMed ID: 38700663
[TBL] [Abstract][Full Text] [Related]
6. Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.
Johnston BD; Thuras P; Porter SB; Anacker M; VonBank B; Snippes Vagnone P; Witwer M; Castanheira M; Johnson JR
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32718965
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo Antimicrobial Activities of Ceftazidime/Avibactam Alone or in Combination with Aztreonam Against Carbapenem-Resistant Enterobacterales.
Lu G; Tang H; Xia Z; Yang W; Xu H; Liu Z; Ni S; Wang Z; Shen J
Infect Drug Resist; 2022; 15():7107-7116. PubMed ID: 36506837
[TBL] [Abstract][Full Text] [Related]
8.
Yu W; Xiong L; Luo Q; Chen Y; Ji J; Ying C; Liu Z; Xiao Y
Front Cell Infect Microbiol; 2021; 11():780365. PubMed ID: 34900759
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial peptide WAM-1: a promising antibacterial and anti-inflammatory drug against carbapenem-resistant Klebsiella pneumoniae.
Zhang X; Shi S; Yao Z; Zheng X; Li W; Zhang Y; Wang L; Cao J; Zhou T
J Antimicrob Chemother; 2022 Jun; 77(7):1903-1911. PubMed ID: 35474013
[TBL] [Abstract][Full Text] [Related]
10. KPC-2 allelic variants in
Sanz MB; Pasteran F; de Mendieta JM; Brunetti F; Albornoz E; Rapoport M; Lucero C; Errecalde L; Nuñez MR; Monge R; Pennini M; Power P; Corso A; Gomez SA
Microbiol Spectr; 2024 Mar; 12(3):e0411123. PubMed ID: 38319084
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Etest and broth microdilution for evaluating the susceptibility of Staphylococcus aureus and Streptococcus pneumoniae to ceftaroline and of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa to ceftazidime/avibactam.
Huang YT; Kuo YW; Teng LJ; Liao CH; Hsueh PR
J Glob Antimicrob Resist; 2021 Sep; 26():301-307. PubMed ID: 34303027
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms Driving the
Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y
mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448
[TBL] [Abstract][Full Text] [Related]
13. The antibacterial activity and mechanism of a novel peptide MR-22 against multidrug-resistant
Tian C; Zhao N; Yang L; Lin F; Cai R; Zhang Y; Peng J; Guo G
Front Cell Infect Microbiol; 2024; 14():1334378. PubMed ID: 38328670
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial Activity of Human Simulated Epithelial Lining Fluid Concentrations of Ceftazidime-Avibactam Alone or in Combination with Amikacin Inhale (BAY41-6551) against Carbapenem-Resistant Pseudomonas aeruginosa and Klebsiella pneumoniae.
Almarzoky Abuhussain SS; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29914950
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against
Han R; Yang X; Yang Y; Guo Y; Yin D; Ding L; Wu S; Zhu D; Hu F
Microbiol Spectr; 2022 Feb; 10(1):e0109221. PubMed ID: 35019685
[TBL] [Abstract][Full Text] [Related]
17. Emergence of Ceftazidime-Avibactam Resistance and Decreased Virulence in Carbapenem-Resistant ST11
Xu M; Qian C; Jia H; Feng L; Shi S; Zhang Y; Wang L; Cao J; Zhou T; Zhou C
Infect Drug Resist; 2022; 15():6881-6891. PubMed ID: 36465808
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of ceftazidime/avibactam resistance in drug-naïve bacteraemic Enterobacterales strains without metallo-beta-lactamase production: Associated with ceftazidime impedance.
Xiong L; Wang Y; Wang X; Zhou Y; Chi X; Chen T; Lu P; Chen Y; Ji J; Xiao Y
Int J Antimicrob Agents; 2023 Aug; 62(2):106877. PubMed ID: 37271474
[TBL] [Abstract][Full Text] [Related]
19. The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant
Nasomsong W; Nulsopapon P; Changpradub D; Pongchaidecha M; Pungcharoenkijkul S; Juntanawiwat P; Simsiriporn W; Santimaleeworagun W
Drug Des Devel Ther; 2021; 15():3095-3104. PubMed ID: 34295150
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients.
Stein GE; Smith CL; Scharmen A; Kidd JM; Cooper C; Kuti J; Mitra S; Nicolau DP; Havlichek DH
Surg Infect (Larchmt); 2019 Jan; 20(1):55-61. PubMed ID: 30351195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
